Skip to main content

Table 3 Results of drug susceptibility testing against M. abscessus and M. massiliense

From: Development of a loop-mediated isothermal amplification coupled lateral flow dipstick targeting erm(41) for detection of Mycobacterium abscessus and Mycobacterium massiliense

Drugs Species No. (%) of strains χ2 P value
Susceptible Intermediate Resistant
Clarithromycin3d M. abscessus 49 (94.2) 1 (1.9) 2 (3.8) 1.010 0.60
M. massiliense 51 (96.2) 0 (0.0) 2 (3.8)   
Clarithromycin14d M. abscessus 9 (17.3) 0 (0.0) 43 (82.7) 65.847 < 0.001
M. massiliense 51 (96.2) 0 (0.0) 2 (3.8)   
Azithromycin M. abscessus 51 (98.1) 1 (1.9) 0.000 1.00
M. massiliense 52 (98.1) 1 (1.9)   
Amikacin M. abscessus 52 (100.0) 0 (0.0) 0 (0.0) 16.178 < 0.001
M. massiliense 39 (73.6) 12 (22.6) 2 (3.8)   
Levofloxacin M. abscessus 0 (0.0) 0 (0.0) 52 (100.0) 0.000 1.00
M. massiliense 0 (0.0) 0 (0.0) 53 (100.0)   
Moxifloxacin M. abscessus 0 (0.0) 5 (9.6) 47 (90.4) 0.542 0.72
M. massiliense 0 (0.0) 3 (5.7) 50 (94.3)   
Gatifloxacin M. abscessus 0 (0.0) 7 (13.5) 45 (86.5) 1.770 0.32
M. massiliense 0 (0.0) 3 (5.7) 50 (94.3)